Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?

Humans

This article has no abstract; the first 100 words appear below.

Cardiogenic shock occurs in approximately 5% of patients with an acute coronary syndrome — usually, but not always, after ST-segment elevation myocardial infarction. If a large amount of myocardial tissue has become ischemic or injured, pump failure and reduced blood flow to vital organs occur. Urgent percutaneous coronary intervention (PCI) of the culprit lesion is currently the only therapy associated with a significant decrease in mortality.1 No other intervention with a device or pharmacologic agent has shown a significant benefit, and as a consequence, mortality has plateaued at 50% in recent years. On angiography performed during the acute phase, clinically . . .

Articles You May Like

Marvel at the plans for Japan’s futuristic new space research center
Public Health Experts On New FDA E-Cigarette Rules: It’s Complicated
Evaluating the impact of topological protein features on the negative examples selection
Timefulness review – our impulsive and pugnacious age needs geology
Here are some of the strangest things on Earth you may not have heard of

Leave a Reply

Your email address will not be published. Required fields are marked *